C34 D14.3
Conditions
Interventions
Group 1: Observational study with patients suspicious for lung cancer and patients with lung diseases
Sponsors
Hummingbird Diagnostics
Eligibility
Sex/Gender
All
Age
55 Years to 80 Years
Inclusion criteria
Inclusion criteria: Male or female patient, 50-80 years old Patient with suspected lung carcinoma (group 1) or patient with benign lung disease (group 2) current or ex-smoker status with = 20 pack-years and with nicotine abstinence < 15 years (if ex-smoker) voluntary written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Other cancer diagnosis (during last 5 years) Known active infectious diseases (e.g., HIV, HBV, HCV) Already started immunomodulatory or neoadjuvant therapy and invasive diagnostics (surgery) before study inclusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To confirm the presence of specific RNA ribonucleotide complex in the blood of lung cancer patients | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate preanalytical criteria for the stabilization of the RNP complex To characterize the (non-genetic) molecular nature of the RNP complex To compare the biochemical properties of the specific RNPs in the lung cancer patients against matched non-cancer control group patients To identify RNA biomarkers that build RNP complexes in plasma of lung cancer patients | — |
Countries
Slovakia
Contacts
Public ContactMichal Urda
FNsP F.D. Roosevelta
Outcome results
None listed